神拓生物致力于打造*的基因治疗和创新的递送技术平台。公司核心成员均来自全球一流的科研机构和知名药企，兼具前沿生物医疗技术和产业管理经验。神拓生物以临床转化应用为导向，着重开发第五代慢病毒载体（5G载体）平台，突破现有载体应用的局限性，为体内基因治疗提供更加安全有效的递送工具。神拓生物将管线布局定位在全球需求迫切，市场潜力巨大的实体肿瘤，特别是神经系统肿瘤，力图填补该领域空白。神拓已和多家国内外顶级科研机构、权威三甲医院、CRO和CDMO建立了合作关系，现已开展多款产品的设计、临床前药效研究和毒理安评工作，近期重点投入在开发针对神经纤维瘤病的基因疗法，力争早日实现同类*创新药。
Provided by
Congratulations, submitted successfully!
Your edit is under review. You will be notified by email within 1 business day.
Submission failed.
Help others learn about this company, add my impression of this company»
Log in with the following accounts to save your follows
Jobui does not provide an APP. Please follow our WeChat official account.
